Status: Recruiting
Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
To investigate the neoadjuvant chemoimmunotherapy regimen of Ivonescimab combined with chemotherapy (Paclitaxel plus Cisplatin/Carboplatin) for the treatment of locally advanced resectable oral squamous cell carcinoma and oropharyngeal squamous cell carcinoma.
Participants needed: 20
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Zhujiang HospitalUpdated: Jul 7, 2026Locations: 2
Eligibility criteria
Histopathologically diagnosed as oral squamous cell carcinoma (OSCC) or orophary... [+7]
Pregnancy or lactation (for female participants) [+3]